XML 51 R37.htm IDEA: XBRL DOCUMENT v3.25.4
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Schedule of Reserved Shares of Common Stock for Future Issuance
As of December 31, 2025 and 2024, the Company had reserved shares of common stock for future issuance as follows:
December 31,
20252024
Options, RSUs and PSUs outstanding20,174,662 20,759,819 
Shares available for future grants92,889,210 84,272,083 
Shares subject to the employee stock purchase plan23,194,449 20,342,607 
Total shares of common stock reserved for future issuance
136,258,321 125,374,509 
Schedule of Stock Option Activity and Weighted Average Exercise Prices
The following table summarizes the Company's stock option activity and weighted-average exercise prices:
Number of
Options
Outstanding
Weighted-
Average
Exercise Price
Weighted-
Average
Remaining
Contractual Life
(in Years)
Aggregate
Intrinsic Value
(in thousands)
Balance—December 31, 20246,953,119$4.55 3.0$961,910 
Options granted— — 
Options exercised(3,478,500)1.84 
Options forfeited or expired— — 
Balance—December 31, 20253,474,619$7.26 3.0$447,294 
Exercisable—December 31, 20253,474,619$7.26 3.0$447,294 
Schedule of Activity for Unvested RSUs
The following table summarizes the activity for the Company’s unvested RSUs and PSUs:
SharesWeighted-Average
Fair Value
Aggregate
Intrinsic Value
(in thousands)
Unvested and outstanding balance as of December 31, 202413,806,700$116.09 $1,972,839 
Awarded9,951,174128.13 
Vested(5,595,469)113.50 
Forfeited/canceled(1,462,362)116.34 
Unvested and outstanding balance as of December 31, 202516,700,043$124.10 $2,271,039 
Schedule of Share-Based Payment Arrangement, Performance Shares, Activity
The following table summarizes the activity for the Company’s unvested RSUs and PSUs:
SharesWeighted-Average
Fair Value
Aggregate
Intrinsic Value
(in thousands)
Unvested and outstanding balance as of December 31, 202413,806,700$116.09 $1,972,839 
Awarded9,951,174128.13 
Vested(5,595,469)113.50 
Forfeited/canceled(1,462,362)116.34 
Unvested and outstanding balance as of December 31, 202516,700,043$124.10 $2,271,039 
Schedule of Stock-based Compensation Expense
Stock-based compensation was included in the consolidated statement of operations as follows (in thousands):
Year Ended December 31,
202520242023
Cost of revenue$29,729 $26,221 $17,578 
Research and development469,526 363,301 313,096 
Sales and marketing156,472 122,079 101,937 
General and administrative94,944 58,735 49,689 
Stock-based compensation, net of amounts capitalized750,671 570,336 482,300 
Capitalized stock-based compensation23,454 13,152 13,597 
Total stock-based compensation$774,125 $583,488 $495,897